Cambridge, MANCT07078422Now EnrollingIRB Ready

Essential Tremor Clinical Trial in Cambridge, MA

Access cutting-edge essential tremor treatment through this clinical trial at a research site in Cambridge. Study-provided care at no cost to qualified participants.

Sponsored by Encora, Inc.

Quick Self-Assessment

See if you qualify for this Cambridge location

Preparing your pre-screening questions…

Expert Care in Cambridge

Access essential tremor specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related essential tremor treatment provided free

Apply for This Cambridge Location

Check if you qualify for this essential tremor clinical trial in Cambridge, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cambridge

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cambridge site if eligible
  4. 4Begin participation

About This Essential Tremor Study in Cambridge

Subjects will receive prototype devices to be used for participation. The study comprises three phases: 1. Alpha phase: Two remote study visits and an in-home period to gather device usability data on the alpha system. The at home period for this phase will be 2 weeks. This phase will be used to confirm that the device and labeling are suitable for in-home use. 2. Beta Phase B1: Beta Phase B1 will be conducted using the beta devices for two in-person or remote, 60 to 90-minute, visits. This phase will be used to assess design changes between alpha and beta versions. 3. Beta Phase B2: Seven remote visits and in-home usage to gather usability and efficacy data on the beta system in-home. Beta Phase B2 will be conducted using the beta devices for 12 weeks. This phase will be used to assess design changes between alpha and beta versions.

Sponsor: Encora, Inc.

Who Can Participate

Inclusion Criteria

- Alpha and Beta Phase B1
Age 18 years or older, able to comply with all study procedures and capable of providing informed consent.
Mentally competent to understand and able to perform written, informed consent to participate in the study
A diagnosis of either ET or PD as determined by clinical history
Moderate to severe upper limb tremor

Exclusion Criteria

- Alpha and Beta Phase B1
Pregnant women
Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site
History of psoriasis, eczema or atopic dermatitis at the stimulation site
History of peripheral neuropathy in the upper limbs, including carpal tunnel syndrome and diabetic neuropathy
Participant unable to communicate with sponsor/investigator and staff
Any other medical conditions or physical or mental impairments that in the sponsor/investigator's opinion would render the subject unsuitable as a candidate for the study. Inclusion Criteria - Beta Phase B2
Age 18 years or older, able to comply with all study procedures and capable of providing informed consent
Mentally competent to understand and able to perform written, informed consent to participate in the study
For ET subjects, a diagnosis of essential tremor defined as definite or probable ET based on TRIG criteria
For PD subjects, a diagnosis of Parkinson's disease by a Movement Disorder Specialist
For ET subjects, at least one hand exhibiting tremor \> 2 as assessed by the Essential Tremor Rating Assessment Scale (TETRAS) finger to nose task, duck wing task, OR Archimedes Spiral completed during the Screening visit
For PD subjects, a score \> 2 on at least one of MDS-UPDRS items 3.15, 3.16 or 3.17 At the Screening Visit, a score of \> 3 on one of the following subject-assessed items of the Bain \& Findley Activities of Daily Living Scale (BF-ADL): Use a spoon to drink soup, Hold a cup of tea, Do up buttons, Do up a zipper, Write a letter
Stable medications for at least 30 days prior to enrollment and the ability to maintain tremor medications throughout the duration of study participation
For PD subjects, able to participate in visits in a practically defined OFF state (withdrawal from all tremor medication for 12 hours prior to study visits)
A wrist circumference of 6.0 - 8.1 inches Exclusion Criteria - Beta Phase B2
Pregnant women
Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site
History of psoriasis, eczema or atopic dermatitis at the stimulation site
History of peripheral neuropathy in the upper limbs, including carpal tunnel syndrome and -diabetic neuropathy
Participant unable to communicate with sponsor/investigator and staff
Any other medical conditions or physical or mental impairments that in the sponsor/investigator's opinion would render the subject unsuitable as a candidate for the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cambridge?

Yes, this clinical trial (NCT07078422) has an active research site in Cambridge, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Essential Tremor Treatment Options in Cambridge, MA

If you're searching for essential tremor treatment options in Cambridge, MA, this clinical trial (NCT07078422) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cambridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced essential tremor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all essential tremor clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Cambridge, MA

See all parkinsons disease clinical trials recruiting in Cambridge — not just this study.

Browse Parkinsons Disease Trials in Cambridge →

Browse More Trials by Condition

Parkinsons Disease TrialsEssential Tremor TrialsAll Conditions →

Ready to Join in Cambridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cambridge, MA